Literature DB >> 17699982

Oligohydrosis underestimated side effect with topiramate treatment.

Eva L W Fung, Edmund A S Nelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17699982     DOI： 10.1007/s12098-007-0124-9

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  6 in total

1.  Age, dose, and environmental temperature are risk factors for topiramate-related hyperthermia.

Authors:  El Khoury Ziad; Amal C Rahi; Sahar Abu Hamdan; Mohamad A Mikati
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

2.  Hypohidrosis during topiramate treatment: a rare and reversible side effect.

Authors:  Caterina Cerminara; Stefano Seri; Roberta Bombardieri; Mariangela Pinci; Paolo Curatolo
Journal:  Pediatr Neurol       Date:  2006-05       Impact factor: 3.372

3.  Severe topiramate-associated hyperthermia resulting in persistent neurological dysfunction.

Authors:  Sharon C Galicia; Steven L Lewis; Leo Verhagen Metman
Journal:  Clin Neuropharmacol       Date:  2005 Mar-Apr       Impact factor: 1.592

4.  Hypohidrosis related to the administration of topiramate to children.

Authors:  J Arcas; T Ferrer; M C Roche; A Martínez-Bermejo; V López-Martín
Journal:  Epilepsia       Date:  2001-10       Impact factor: 5.864

5.  Oligohydrosis and hyperthermia: pilot study of a novel topiramate adverse effect.

Authors:  Bruria Ben-Zeev; Nathan Watemberg; Arie Augarten; Nathan Brand; Yaakov Yahav; Ori Efrati; Leon Topper; Ilan Blatt
Journal:  J Child Neurol       Date:  2003-04       Impact factor: 1.987

6.  Transient hypohidrosis induced by topiramate.

Authors:  Piero de Carolis; Fabiola Magnifico; Giulia Pierangeli; Rita Rinaldi; Massimo Galeotti; Sabina Cevoli; Pietro Cortelli
Journal:  Epilepsia       Date:  2003-07       Impact factor: 5.864
  6 in total
  1 in total

1.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.